GTC Biotherapeutics (fka GTCB)

[croumagnon]

Re: "New shares and options for executive officers."

Not too bad and deserved from the point of view of technological progress, although not deserved from the point of view of financing and business deals. Hopefully this will mark the beginning of a pps rise...

I lost track but as I recall these options exercisable at $0.63 are the cheapest options they have. So, I suppose going froward our interest and those of management are aligned in terms of wanting a higher pps...